Skyline Medical Reports Third Quarter 2016 Financial Results

November 15, 2016

MINNEAPOLIS, Nov. 15, 2016, SKLN, (GLOBE NEWSWIRE) Skyline Medical Inc. (SKLN) (“Skyline” or “the Company”), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three and nine months ended September 30, 2016. Highlights of the third quarter of 2016 and recent weeks include: Signed an agreement with GLG Pharma, Inc. to be the exclusive distributor of the STREAMWAY System in the U.K., Poland and certain Central European countries Entered into a
http://bit.ly/2gdpiLL


DynaResource, Inc. Reports September 2016 Gold Production and Results of Operations at San Jose de Gracia

October 19, 2016

IRVING, TX DYNR, (Marketwired Oct 19, 2016) DynaResource, Inc. (OTCQB: DYNR) ( DynaUSA, and the Company ) is pleased to announce that Mineras de DynaResource S.A. de C.V. ( DynaMineras ), the 100% owned subsidiary of DynaUSA and the exclusive operator of the San Jose de Gràcia Property in northern Sinaloa, México ( SJG ), is reporting the delivery for sale, on October 13, 2016, of an approximate 500 oz. gold contained in concentrates (exact weights in gold and silver oz. to be determined
http://bit.ly/2ekyOs2


Marijuana Company of America Q4 2016 Outlook and Update

October 18, 2016

BONSALL, CA MCOA, (Marketwired Oct 18, 2016) hempSMART Brain product release imminent Offers brain support and protection Product is first-of-its-kind Fulfillment center prepared to manage distribution of orders Members signing up for PreLaunch MARIJUANA COMPANY OF AMERICA INC., ( MCOA or the Company ) (OTC PINK: MCOA), an innovative cannabis and hemp marketing and distribution company, is providing this update to keep our shareholders and prospective investors informed. Our first product, hempSMART BRAIN, formulated with CBD or Cannabidiol as the core
http://bit.ly/2e4vMx6


Arch Therapeutics Will Present at the 2016 Bio Investor Forum in San Francisco, California October 18-19th, 2016

October 11, 2016

FRAMINGHAM, MA (Marketwired Oct 11, 2016) Arch Therapeutics, Inc. (OTCQB: ARTH) ( Arch or the Company ), developer of AC5™ devices for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, today announced that it will be featured as a presenting company at the BIO Investor Forum taking place from October 18-19, 2016 at the Westin St. Francis Hotel in San Francisco, California. Terrence W. Norchi, MD, CEO is scheduled to present
http://bit.ly/2dIJSnD


FutureWorld (FWDG) 2016 Year in Review

August 16, 2016

Better Business Model, Better Investments & Better ROI ST. PETERSBURG, FL FWDG, (Marketwired August 16, 2016) FutureWorld Corp (FWDG), a Cannabis technology incubator & accelerator, provides the following year in review to its shareholders. Dear Shareholders; Cannabis industry is the fastest-growing industry in the United States and had its biggest year ever which could grow by another eight to 10 states in 2016. With the presidential election looming, there is guaranteed to be a massive voter turnout and the
http://bit.ly/2bvpzED


DynaResource, Inc. Reports June 2016 Gold Production and Results of Operations at San Jose de Gracia

July 8, 2016

IRVING, TX DYNR, (Marketwired Jul 8, 2016) (OTCQB: DYNR) DynaResource, Inc. ( DynaUSA , and the Company ) is pleased to announce that Mineras de DynaResource S.A. de C.V. ( DynaMineras ), the 100% owned subsidiary of DynaUSA and the exclusive operator of the San Jose de Gràcia Property in northern Sinaloa, México ( SJG ), is reporting the delivery for sale, on June 30, 2016, of an approximate 425 Oz gold contained in concentrates (exact weights in gold and silver oz. to be determined The post DynaResource, Inc. Reports June 2016 Gold Production and Results of Operations at San Jose de Gracia appeared first on Public Wire.
http://bit.ly/29mAPFh


Arch Therapeutics Announces May 26, 2016 $3.4 Million Private Placement

May 27, 2016

FRAMINGHAM, MA ARTH, (Marketwired May 27, 2016) Arch Therapeutics, Inc. (OTCQB: ARTH) ( Arch or the Company ), developer of the AC5 Surgical Hemostatic Device™ (AC5™) for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, is pleased to announce that it has entered into subscription agreements with a group of accredited investors (the Investors ) to purchase approximately $3.4 million of the Company s securities in a private placement pursuant to Section The post Arch Therapeutics Announces May 26, 2016 $3.4 Million Private Placement appeared first on Public Wire.
http://bit.ly/1NSoDel